Myasthenia gravis is a chronic autoimmune disorder that inhibits communication between nerve cells and muscles, causing muscle weakness. It has no cure, but several treatment options can help improve ...

Minimally invasive treatment and earlier surgical consideration for thymectomy led the way as potential treatments for patients with ocular myasthenia gravis (OMG) in a new investigation, due to ...

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Patients with myasthenia gravis who received treatment within a year from diagnosis were generally in accordance with guideline suggestions. Most patients with myasthenia gravis (MG) are treated with ...

Drooping eyelids, referred to as ptosis, are a common symptom of myasthenia gravis. The disease can weaken muscles around the eye, as well as muscles involved with walking, breathing, and more.

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad population of antibody positive ...

Andrea Divis was shocked to learn that her symptoms of fatigue, blurred vision, and muscle weakness were due to a rare condition called myasthenia gravis. Here’s how she educated herself and took back ...

SAN FRANCISCO -- Intravenous efgartigimod (Vyvgart) met its primary endpoint in adults with acetylcholine receptor (AChR) antibody-negative myasthenia gravis, the ADAPT SERON trial showed. At week 4, ...

Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue," says Hesterlee. It occurs "when a person’s immune system is essentially attacking ...